Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, April 30, 2013 Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Read More:
Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

Share and Enjoy:
  • Print
  • Digg
  • StumbleUpon
  • Facebook
  • Yahoo! Buzz
  • Twitter
  • Google Bookmarks
  • Add to favorites
  • email
  • LinkedIn
  • RSS
  • Tumblr
Share